According to the Russian news agency TASS, the nation has created its own cancer vaccine.
Andrey Kaprin, the general director of the Russian Ministry of Health’s Radiology Medical Research Centre, told Radio Rossiya that the mRNA vaccine, which prevents cancer, will be given to patients at no cost.
It is anticipated that the vaccine, which was created in collaboration with multiple research facilities, will be made available to the general public by early 2025.
The director of the Gamaleya National Research Centre for Epidemiology and Microbiology, Alexander Gintsburg, previously told TASS that pre-clinical studies demonstrated the vaccine’s ability to inhibit tumor growth and stop possible metastases.
“The vaccine’s pre-clinical trials had shown that it suppresses tumor development and potential metastases,” Andrey Kaprin told TASS.
Earlier this year, Russian President Vladimir Putin said in televised comments that “we have come very close to the creation of so-called cancer vaccines and immunomodulatory drugs of a new generation”.
“I hope that soon they will be effectively used as methods of individual therapy,” he added, speaking at a Moscow forum on future technologies.
How the Vaccine Work
A tiny piece of messenger RNA, a molecule that conveys particular instructions from DNA, is used in an mRNA vaccination to tell the body’s cells to make a particular protein linked to cancer cells.
This successfully teaches the body to target the disease by causing the immune system to recognize and fight those cancer cells.
In contrast to conventional vaccines, which frequently employ inactivated or weakened pathogens, mRNA vaccines make use of the body’s cellular machinery to precisely target the immune system to the malignancy being treated.
